Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Bladder Cancer

Free Subscription Articles published in Cancer Retrieve available abstracts of 44 articles: HTML format Text format

Single Articles

December 2011
1. KOAY EJ , Teh BS, Paulino AC, Butler EB, et al
   A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends.
   Cancer. 2011;117:5325-33.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
2. ABOGUNRIN F , O'Kane HF, Ruddock MW, Stevenson M, et al
   The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria.
   Cancer. 2011 Sep 14. doi: 10.1002/cncr.26544.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. LOTAN Y
   The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria.
   Cancer. 2011 Sep 14. doi: 10.1002/cncr.26535.
   PubMed     Text format     Related articles   
   
   
   
   August 2011
4. CHAMIE K , Saigal CS, Lai J, Hanley JM, et al
   Quality of care in patients with bladder cancer: A case report?
   Cancer. 2011 Aug 5. doi: 10.1002/cncr.26402.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   July 2011
5. INOUE K , Fukuhara H, Shimamoto T, Kamada M, et al
   Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer.
   Cancer. 2011 Jul 19. doi: 10.1002/cncr.26378.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. CHAMIE K , Saigal CS, Lai J, Hanley JM, et al
   Compliance with guidelines for patients with bladder cancer: Variation in the Delivery of Care.
   Cancer. 2011 Jul 11. doi: 10.1002/cncr.26198.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. SONPAVDE G , Shariat SF
   Preoperative chemotherapy for bladder cancer: A standard waits to be optimally deployed.
   Cancer. 2011 Jul 5. doi: 10.1002/cncr.26239.
   PubMed     Text format     Related articles   
   
   
   
   
8. SHARIAT SF , Savage C, Chromecki TF, Sun M, et al
   Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: A decision-curve analysis.
   Cancer. 2011;117:2892-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   June 2011
9. WOSNITZER MS , Hruby GW, Murphy AM, Barlow LJ, et al
   A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer.
   Cancer. 2011 Jun 29. doi: 10.1002/cncr.26278.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. XING J , Dinney CP, Shete S, Huang M, et al
    Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer.
    Cancer. 2011 Jun 20. doi: 10.1002/cncr.26224.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
11. ALVA AS , Tallman CT, He C, Hussain MH, et al
    Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer: A multidisciplinary approach.
    Cancer. 2011 May 19. doi: 10.1002/cncr.26240.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. SHIGEHARA K , Sasagawa T, Kawaguchi S, Nakashima T, et al
    Etiologic role of human papillomavirus infection in bladder carcinoma.
    Cancer. 2011;117:2067-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
13. WU CT , Wu CF, Lu CH, Lin CC, et al
    Expression and function role of DNA methyltransferase 1 in human bladder cancer.
    Cancer. 2011 Apr 26. doi: 10.1002/cncr.26150.
    PubMed     Text format     Related articles   
    
    
    
    
14. MACKENZIE T , Zens MS, Ferrara A, Schned A, et al
    Diabetes and risk of bladder cancer: Evidence from a case-control study in New England.
    Cancer. 2011;117:1552-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
15. STENZL A , Penkoff H, Dajc-Sommerer E, Zumbraegel A, et al
    Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy : A multicenter randomized, double-blind, placebo-controlled trial.
    Cancer. 2011;117:938-47.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
16. SHARIAT SF , Savage C, Chromecki TF, Sun M, et al
    Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis.
    Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
17. SCHULTZ L , Albadine R, Hicks J, Jadallah S, et al
    Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy.
    Cancer. 2010;116:5517-26.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
18. MACKENZIE T , Zens MS, Ferrara A, Schned A, et al
    Diabetes and risk of bladder cancer: evidence from a case-control study in New England.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. STENZL A , Penkoff H, Dajc-Sommerer E, Zumbraegel A, et al
    Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy : a multicenter randomized, double-blind, placebo-controlled trial.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
20. KRAMER MW , Escudero DO, Lokeshwar SD, Golshani R, et al
    Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. SHAH JB , Kamat AM
    Fluorescence cystoscopy for nonmuscle invasive bladder cancer: is the honeymoon over for the blue light special?
    Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
22. CAFFO O , Fellin G, Graffer U, Mussari S, et al
    Gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer: long-term cumulative results of 2 prospective single-institution studies.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. CAI T , Malossini G
    Bladder cancer and BCG response prediction: what we must know?
    Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
24. ARDELT PU , Riedmiller H, Arap W
    Reply to bladder cancer and BCG response prediction: What we must know?
    Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    September 2010
25. RAJ GV , Karavadia S, Schlomer B, Arriaga Y, et al
    Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
26. LUGHEZZANI G , Sun M, Shariat SF, Budaus L, et al
    A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. FERRUCCI LM , Sinha R, Ward MH, Graubard BI, et al
    Meat and components of meat and the risk of bladder cancer in the NIH-AARP Diet and Health Study.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
28. PORTER MP
    Examining the association between delay in diagnosis and decreased survival in bladder cancer.
    Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
29. HOLLENBECK BK , Dunn RL, Ye Z, Hollingsworth JM, et al
    Delays in diagnosis and bladder cancer mortality.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. UMBREIT EC , Crispen PL, Shimko MS, Farmer SA, et al
    Multifactorial, site-specific recurrence model after radical cystectomy for urothelial carcinoma.
    Cancer. 2010;116:3399-407.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. MA Y , Yu WD, Trump DL, Johnson CS, et al
    1,25D(3) Enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models.
    Cancer. 2010;116:3294-303.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
32. SVATEK RS , Shah JB, Xing J, Chang D, et al
    A multiplexed, particle-based flow cytometric assay identified plasma matrix metalloproteinase-7 to be associated with cancer-related death among patients with bladder cancer.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. BECKER M , Szarvas T, Wittschier M, Vom Dorp F, et al
    Prognostic impact of plasminogen activator inhibitor type 1 expression in bladder cancer.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. ELIAS K , Svatek RS, Gupta S, Ho R, et al
    High-risk patients with hematuria are not evaluated according to guideline recommendations.
    Cancer. 2010;116:2954-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
35. HOLLINGSWORTH JM , Zhang Y, Krein SL, Ye Z, et al
    Understanding the variation in treatment intensity among patients with early stage bladder cancer.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
36. HEMANI ML , Bennett CL
    The excessive cost of early stage bladder cancer care: are providers really to blame?
    Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    March 2010
37. GORE JL , Porter MP
    Patterns of questionable quality care in nonmuscle invasive bladder cancer.
    Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
38. SANDHU R , Pan CX, Wun T, Harvey D, et al
    The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. STROPE SA , Ye Z, Hollingsworth JM, Hollenbeck BK, et al
    Patterns of care for early stage bladder cancer.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. PENSON DF
    Medicare reimbursement changes for bladder biopsies: a cautionary tale of unintended consequences.
    Cancer. 2010;116:1153-4.
    PubMed     Text format     Related articles   
    
    
    
    February 2010
41. FANG AC , Ahmad AE, Whitson JM, Ferrell LD, et al
    Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. DI LORENZO G , Perdona S, Damiano R, Faiella A, et al
    Gemcitabine versus bacille Calmette-Guerin after initial bacille Calmette-Guerin failure in non-muscle-invasive bladder cancer: a multicenter prospective randomized trial.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. HEMANI ML , Makarov DV, Huang WC, Taneja SS, et al
    The effect of changes in Medicare reimbursement on the practice of office and hospital-based endoscopic surgery for bladder cancer.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. ARDELT PU , Kneitz B, Adam P, Reiss C, et al
    Reactive antibodies against bacillus Calmette-Guerin heat-shock protein-65 potentially predict the outcome of immunotherapy for high-grade transitional cell carcinoma of the bladder.
    Cancer. 2010;116:600-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: